Insider Trading Activity For Edwards Lifesciences Corporation (NYSE:EW)
Michael A. Mussallem , CEO of Edwards Lifesciences Corporation (NYSE:EW) reportedly Sold 32,900 shares of the company’s stock at an average price of 115.99 for a total transaction amount of $3,816,071.00 SEC Form
Insider Trading History For Edwards Lifesciences Corporation (NYSE:EW)
Analyst Ratings For Edwards Lifesciences Corporation (NYSE:EW)
These are 5 Hold Ratings, 14 Buy Ratings, 1 Strong Buy Rating .
The current consensus rating for Edwards Lifesciences Corporation (NYSE:EW) is Buy (Score: 2.80) with a consensus target price of $120.47 , a potential (5.56% upside)
Analyst Ratings History For Edwards Lifesciences Corporation (NYSE:EW)
- On 1/4/2016 Sterne Agee CRT Boost Price Target of rating Buy with a price target of $90.00 to $92.00
- On 3/17/2016 Nomura Initiated Coverage of rating Buy with a price target of $101.00
- On 6/21/2016 Piper Jaffray Companies Reiterated Rating Overweight with a price target of $123.00
- On 6/21/2016 William Blair Reiterated Rating Outperform
- On 7/27/2016 BMO Capital Markets Reiterated Rating Buy with a price target of $120.00
- On 7/27/2016 Citigroup Inc Boost Price Target of rating Sell with a price target of $86.00 to $94.00
- On 8/19/2016 Morgan Stanley Reiterated Rating Buy with a price target of $140.00
Recent Trading Activity for Edwards Lifesciences Corporation (NYSE:EW)
Shares of Edwards Lifesciences Corporation closed the previous trading session at 114.13 down -2.13 -1.83% with 982,136 shares trading hands.